Medical laboratory testing, as a crucial means of assessing human health status, facilitates the screening of various diseases in humans,
Diagnosis, treatment, and monitoring, providing critical, scientifically grounded guidance to help individuals effectively manage their health and improve their quality of life. With the accelerating aging of the population, the rising number of chronic disease patients, and continuous population growth, the demand for laboratory testing is increasing steadily, underscoring its growing importance. Particularly in the face of sudden public health emergencies, there is an urgent need to ensure safe, rapid, and accurate detection while simultaneously meeting emergency requirements such as automated, high-throughput screening. During the fight against the novel coronavirus, viral testing stepped into the spotlight, serving as the “first line of defense” for humanity in combating the pandemic.
Clinical laboratories are one of the key support departments responsible for completing testing tasks. As the demand for testing continues to rise, the pressure and challenges facing clinical laboratories are also increasing. However, many factors can lead to inefficient laboratory operations, such as inflexible design, disjointed workflows, numerous and complex operational steps, and uncertain reliability of results. In a static environment, these hidden inefficiencies may be manageable; however, once test volumes increase or new requirements emerge, the impact of low laboratory efficiency becomes more pronounced. To achieve high-throughput sample processing, many laboratories have gradually implemented automation. Nevertheless, in future environments, relying solely on traditional high-throughput automation solutions will no longer meet the demands.
As a brand-new laboratory automation solution,
AbbottThe GLP System Brings New Breakthroughs to Laboratories. This system offers greater flexibility and a wider selection of proven technologies, better meeting the demands of high-throughput testing. With its official launch in China this September, the GLP system will also help laboratories in China further advance their automation development and enhance flexibility management. Its features include:
•Flexible Changes—Efficiently utilize limited space to connect multi-floor and multidisciplinary laboratories while maintaining clear aisles, thereby facilitating better integration of laboratory resources and improving work efficiency.
•Simple and Intuitive—Standardized components support end-to-end solutions, facilitating more effective troubleshooting, ensuring a consistent user experience, and simplifying both training and usage.
•Excellent Performance— Continuously implement dynamic sample management, fully ensure uptime, and enhance laboratory operational efficiency.
With its exceptional flexibility, efficiency, and stability, the GLP system has been installed in over 30 laboratories worldwide. In China, it will continue to help an increasing number of high-throughput laboratories develop personalized solutions tailored to diverse needs, thereby driving comprehensive improvements in healthcare performance.
As a global leader in the diagnostics field, Abbott is committed to continuously delivering significant innovations with substantial medical value to the industry, meeting the growing demand for testing, and providing timely and accurate information to patients and physicians. Since launching its diagnostics business in 1972, Abbott has been at the forefront of the industry’s development, holding the number one global position in areas such as immunoassays and blood screening. Meanwhile, addressing ubiquitous pain points in laboratories and meeting their evolving needs continue to drive Abbott Diagnostics forward. With the introduction of the GLP system, Abbott will further help enhance laboratory
DiagnosisQuality and efficiency drive the development of China's healthcare industry, helping more people lead healthy and fulfilling lives. (Bioon.com)